Cyprus tops Europe for drug-resistant Klebsiella blood infections
Cyprus recorded the highest rate of bloodstream infections from carbapenem-resistant Klebsiella in the EU/EEA in 2025, nearly six times the European average, according to ECDC data.
Cyprus recorded the highest rate in the EU and EEA of bloodstream infections caused by Klebsiella bacteria that resist carbapenem antibiotics, according to data published on Wednesday by the European Centre for Disease Prevention and Control (ECDC). The 2025 figure was 21.29 cases per 100,000 people, compared with a European average of roughly 3.7.
Several other resistant organisms also appear at elevated levels on the island. Third-generation cephalosporin-resistant Klebsiella reached 30.28 per 100,000, versus about 9.2 across Europe, while similar E. coli infections stood at 23.30 against a European figure of about 12.
MRSA bloodstream infections fell to 12.07 from 13.63 in 2024, still above the European average of about 4.5. Carbapenem-resistant Acinetobacter dropped sharply, to 7.57 in 2025 from 29.61 in 2021.
What it means for residents
These infections mostly strike people already weakened by illness and spread inside healthcare settings, so the figures matter most when you or a family member is admitted to hospital. Little changes for daily life outside, but there are practical steps worth taking.
- In hospital: wash your hands and ask visitors to do the same, and check with staff on isolation and hygiene rules for the ward.
- Antibiotics: do not expect a prescription for colds or flu — these drugs do nothing against viruses and fuel resistance.
- Children: ask whether an antibiotic is genuinely needed before giving one to a child.
"requires intensive, coordinated and continuous efforts" — Constantinos Tsioutis, scientific coordinator of the European Committee on Infection Control
This text is written from the source article and is not a translation of it.